- Advertisement -
Breaking
By
mediahyde

Two Merchant Vessels Struck in Red Sea Amid Collapsing Regional Diplomacy

RED SEA — Two commercial ships reported direct hits from projectile fire off the coast of Yemen today, an escalation that has effectively stalled back-channel negotiations aimed at de-escalating the…

Headlines

HeadlineMetropolitan

Sindh and Federal Government Revive Karachi Circular Railway Project

KARACHI — The federal and provincial governments have agreed to revive the…

By
mediahyde
WASHINGTON: UnitedHealth has warned that the Trump administration’s planned Medicare obesity-drug pilot faces “notable challenges,” casting doubt over how smoothly the program can move ahead if major insurers stay cautious. Recent market reporting said the model depends heavily on participation from Medicare drug plans that cover most Part D enrollees, which makes the stance of large insurers especially important. The concern centers on a broader CMS effort to expand access to GLP-1 weight-loss medicines for seniors. Under CMS’s published framework, the longer-term BALANCE Model would begin in Medicare Part D in January 2027, while a temporary Medicare GLP-1 Bridge is designed to start earlier and give eligible beneficiaries short-term access before that main model begins. What makes this a little more complicated is that the short-term bridge and the longer pilot are not the same thing. CMS says the Medicare GLP-1 Bridge operates outside the normal Part D coverage and payment flow, meaning Part D sponsors are not directly involved in that bridge arrangement. In other words, insurer participation is a much bigger issue for the 2027 BALANCE rollout than for the bridge itself. That distinction matters because investors and drugmakers are watching this closely. Reports said shares of obesity-drug makers fell after UnitedHealth’s comments, largely because Medicare coverage is seen as a huge growth opportunity for drugs such as Wegovy and Zepbound. If major insurers hesitate, the program could struggle to achieve the scale CMS appears to want. There is already some evidence of resistance. MarketWatch reported that CVS Health has opted out, while UnitedHealth is still evaluating the structure and discussing possible changes with Medicare officials. That does not mean the program is dead, not yet anyway, but it does suggest the administration may need to revise the design or sweeten the terms if it wants broader insurer buy-in. The bigger backdrop here is cost. Medicare has long been wary of broad obesity-drug coverage because GLP-1 therapies are expensive and potentially involve very large patient populations. Earlier policy debates around these drugs were shaped by concerns that wide coverage could drive up federal spending sharply, even as supporters argued the medicines could reduce longer-term health costs tied to obesity. So the headline problem for CMS is pretty straightforward: it has created a short-term bridge that can move without direct Part D plan involvement, but the more ambitious long-term Medicare model still appears to need insurers on board. UnitedHealth’s warning does not shut the door, but it does signal that one of the industry’s biggest players thinks the current setup may not be ready for easy launch.
HeadlineHealth

UnitedHealth raises red flags over Medicare obesity-drug pilot

WASHINGTON: UnitedHealth has warned that the Trump administration’s planned Medicare obesity-drug pilot…

By
Mabruka Khan
Headline

Iran Tensions Rise: Vance’s Talks Trip Paused for Now

Vice President JD Vance’s trip to Pakistan for a second round of…

By
Shabih Abbas
- Advertisement -

Iranian gunboat fires on container ship near Omani coast

 Iranian gunboat fires on container ship near Omani coast A…

By
Amna Iqbal

Tiny Pacific nations face tough choices on food, fuel posed by Iran war

Tiny Pacific island nations are facing an ugly, familiar dilemma:…

By
Mabruka Khan

Kuwait revokes citizenship of 172 individuals in latest batch

KUWAIT CITY, April 22 — Kuwait has revoked the citizenship…

By
Ayan Ahmed

Sindh scraps BRT Red Line construction contract, plans emergency re-award

The Sindh government has cancelled a key construction contract for…

By
Aqil Rahman

Iran War 2026- Live Updates: Trump announces extension in Iran ceasefire at PM Sharif, Field Marshal Munir’s request

President Donald Trump said on April 21 that the United…

By
Abdul Saboor
Fly Jinnah to start twice-daily Islamabad–Lahore flights on May 1

Fly Jinnah to start twice-daily Islamabad–Lahore flights on May 1

Fly Jinnah is set to launch a new twice-daily service…

By
Mabruka Khan
Wahdat Poultry IPO five times oversubscribed as strike price lands at Rs18

Wahdat Poultry IPO five times oversubscribed as strike price lands at Rs18

Wahdat Poultry Farm Limited’s initial public offering has drawn a…

By
Yamna Shahid
Saudi Riyal Remains Stable Against Pakistani Rupee on April 21

Saudi Riyal Remains Stable Against Pakistani Rupee on April 21

The Saudi Riyal (SAR) remained largely stable against the Pakistani…

By
Misbah Jogyat

Kafeel: Aashir Wajahat’s parents hail his powerful turn as Subuk

Aashir Wajahat is getting a very public, very emotional round…

By
Ayan Ahmed
Beef Season 2 opens far below breakout first season, despite solid reviews

Beef Season 2 opens far below breakout first season, despite solid reviews

Netflix’s Beef has returned with a new cast, a new…

By
Yamna Shahid
Akshay Kumar backs Wamiqa Gabbi, says comparisons with Aishwarya Rai miss the point

Akshay Kumar backs Wamiqa Gabbi, says comparisons with Aishwarya Rai miss the point

Akshay Kumar has come out firmly in support of his…

By
Yamna Shahid
FC Basel cancels planned Ye concert at St. Jakob-Park

FC Basel cancels planned Ye concert at St. Jakob-Park

Swiss football club FC Basel has canceled a planned concert…

By
Ayesha Masood
Four Suspects Arrested in Karachi Crackdown on Matric Exam Paper Leak Gangs

Four Suspects Arrested in Karachi Crackdown on Matric Exam Paper Leak Gangs

Karachi police have arrested four suspects during a targeted operation…

By
Misbah Jogyat
UK Moves to Legally Ban Mobile Phones in Schools Across England

UK Moves to Legally Ban Mobile Phones in Schools Across England

Britain is moving to make school phone bans a matter…

By
Misbah Jogyat
Oman Grants Citizenship to 226 Individuals Through Royal Decree

Oman Grants Citizenship to 226 Individuals Through Royal Decree

Oman has granted citizenship to 226 individuals under a new…

By
Misbah Jogyat

Ismail Industries Holds Successful Recruitment Drive at AIT

Karachi: Ismail Industries Limited conducted a successful recruitment drive at…

By
Alisha Akhtar
WASHINGTON: UnitedHealth has warned that the Trump administration’s planned Medicare obesity-drug pilot faces “notable challenges,” casting doubt over how smoothly the program can move ahead if major insurers stay cautious. Recent market reporting said the model depends heavily on participation from Medicare drug plans that cover most Part D enrollees, which makes the stance of large insurers especially important. The concern centers on a broader CMS effort to expand access to GLP-1 weight-loss medicines for seniors. Under CMS’s published framework, the longer-term BALANCE Model would begin in Medicare Part D in January 2027, while a temporary Medicare GLP-1 Bridge is designed to start earlier and give eligible beneficiaries short-term access before that main model begins. What makes this a little more complicated is that the short-term bridge and the longer pilot are not the same thing. CMS says the Medicare GLP-1 Bridge operates outside the normal Part D coverage and payment flow, meaning Part D sponsors are not directly involved in that bridge arrangement. In other words, insurer participation is a much bigger issue for the 2027 BALANCE rollout than for the bridge itself. That distinction matters because investors and drugmakers are watching this closely. Reports said shares of obesity-drug makers fell after UnitedHealth’s comments, largely because Medicare coverage is seen as a huge growth opportunity for drugs such as Wegovy and Zepbound. If major insurers hesitate, the program could struggle to achieve the scale CMS appears to want. There is already some evidence of resistance. MarketWatch reported that CVS Health has opted out, while UnitedHealth is still evaluating the structure and discussing possible changes with Medicare officials. That does not mean the program is dead, not yet anyway, but it does suggest the administration may need to revise the design or sweeten the terms if it wants broader insurer buy-in. The bigger backdrop here is cost. Medicare has long been wary of broad obesity-drug coverage because GLP-1 therapies are expensive and potentially involve very large patient populations. Earlier policy debates around these drugs were shaped by concerns that wide coverage could drive up federal spending sharply, even as supporters argued the medicines could reduce longer-term health costs tied to obesity. So the headline problem for CMS is pretty straightforward: it has created a short-term bridge that can move without direct Part D plan involvement, but the more ambitious long-term Medicare model still appears to need insurers on board. UnitedHealth’s warning does not shut the door, but it does signal that one of the industry’s biggest players thinks the current setup may not be ready for easy launch.

UnitedHealth raises red flags over Medicare obesity-drug pilot

WASHINGTON: UnitedHealth has warned that the Trump administration’s planned Medicare…

By
Mabruka Khan

COVID shots, newer vaccines in limbo after US court halts Kennedy’s advisory panel

The future of COVID-19 vaccinations in the United States has…

By
Shabih Abbas

DRAP Takes Strict Notice of Illegal Online Sale and Advertisement of Medicines

The Drug Regulatory Authority of Pakistan DRAP has taken strict…

By
Neha Ashraf

Climate & Weather

More Post

Karachi Street Crime Case Puts Spotlight on Evolving Tactics, as Police Arrest Gang Linked to 100+ Robberies

Karachi’s street-crime problem has taken another unsettling turn, with fresh…

By
Hifza Ahmed

KARACHI: A minor girl was allegedly sexually assaulted in Karachi after being abducted from Sadiqabad in Punjab, police said on Monday.

KARACHI: A minor girl was allegedly sexually assaulted in Karachi…

By
Umer Abdullah

Lahore scooty robbery suspect hurt in alleged police encounter, arrested

  A suspect police say was involved in the robbery…

By
Hifza Ahmed

Sri Lankan government demands cricket board’s resignation after World Cup collapse

  Sri Lanka’s sports ministry told the national cricket board…

By
Ayan Ahmed

Mohammad Nawaz Under PCB Investigation Following Positive Drug Test

Karachi, April 2026 — Pakistani all-rounder Mohammad Nawaz has come under formal investigation by the…

By
Muzammil Nabi Khan

Fakhar Zaman’s century hands Qalandars a must-have win in Lahore

Lahore Qalandars kept their PSL 2026 campaign alive on Tuesday, April 21, with a 9-run…

By
Zain Abbas
HeadlineMetropolitan

Sindh and Federal Government Revive Karachi Circular Railway Project

KARACHI — The federal and provincial governments have agreed to…

By
mediahyde

Gul Plaza Fire a Major Tragedy, Government Must Act Seriously: Shahid Khaqan Abbasi

Karachi — Chairman Awam Pakistan Party and former Prime Minister Shahid Khaqan Abbasi has termed…

By
Aiza Uddin

Principled Agreement Reached on Peoples Train Service in Balochistan, Decision to Extend Service From Sariab to Kuchlak and Further to Mastung and Pishin

A high level meeting was held at the Chief Minister Secretariat Quetta under the chairmanship…

By
Neha Ashraf
Pakistan Condemns Storming of Al-Aqsa Mosque, Calls Israeli Flag Raising ‘Reprehensible’

Pakistan Condemns Storming of Al-Aqsa Mosque, Calls Israeli Flag Raising ‘Reprehensible’

Pakistan has strongly condemned the reported storming of the Al-Aqsa…

By
Misbah Jogyat

Israeli Soldiers Punished Over Vandalism of Jesus Statue in Lebanon

Two Israeli soldiers have been punished after a photograph showing one of them damaging a…

By
Syed Jarri Abbas

Rabbi Accused of War Crimes Chosen for Israel’s Flagship Independence Day Ceremony

Israel’s decision to select Rabbi Avraham Zarbiv as a torchlighter for its 2026 Independence Day…

By
Syed Jarri Abbas